David Rothkopf is a seasoned expert in medical device regulatory strategy, quality systems, and clinical validation, with over 30 years of experience in the industry.
As President of MEDIcept Inc., he has advised more than 400 medtech companies on FDA submissions, CE Marking, ISO 13485 compliance, and clinical trial design.David served as a lead mentor to AVaTAR MedTech during our participation in the MIT linQ IDEA² program.
His guidance was instrumental in shaping our early regulatory and QMS roadmap. Following the program, he formally joined as an advisor to support our go-to-market and FDA strategy as we scale toward clinical adoption.
.png)